Leaflet RHESONATIV 625UI / ml solution for injection
Indicated for: immunosuppression
Route of administration: injectable
Substance: anti-D immunoglobulin (immunoglobulin)
ATC: J06BB01 (Antiinfectives for systemic use | Immunoglobulins | Specific immunoglobulins)
Risk of severe allergic reaction. Seek urgent medical help if serious symptoms occur.
This medicine is subject to additional monitoring.
Anti-D immunoglobulin is a medication used to prevent Rh isoimmunization in Rh-negative women who have been exposed to Rh-positive blood, such as during pregnancy or childbirth. It contains antibodies that neutralize Rh-positive cells, thereby preventing the formation of antibodies against them.
The medication is administered via intramuscular or intravenous injection, according to the doctor's instructions. It is effective in preventing hemolytic complications in subsequent pregnancies.
Side effects may include pain at the injection site, fever, headache, and, in rare cases, severe allergic reactions. Close monitoring is essential during treatment.
Consult your doctor to discuss the benefits and risks of treatment with anti-D immunoglobulin. Follow the administration instructions to ensure therapy effectiveness.
General data about RHESONATIV 625UI / ml
- Substance: anti-D immunoglobulin
- Date of latest medicines list: 01-06-2021
- Product code: W52402002
- Concentration: 625UI / ml
- Pharmaceutical form: solution for injection
- Packing volume: 1ml
- Product type: Original
- Prescription status: P-RF - Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.
Pharmaceutical forms available for anti-D immunoglobulin
Concentrations available for anti-D immunoglobulin
- 300mcg
- 300mcg/2ml
- 625UI/ml
- 750UI/ml